The groundbreaking rise of Viagra has consistently remained a benchmark of pharmaceutical success, but its future within the broader market now presents questions about long-term yields . Generic versions are diminishing market share, leading to anxieties that betting on companies heavily reliant to Viagra's once-dominant influence could be a dange